Quirin Hammer
@QuirinHammer
Scientist with focus on #NKcells and innate-like #Tcells in #virus infections and #immunotherapy | team leader at @CIM_sweden | @DRFZ_Berlin alumnus
A KI study published in @PLOSPathogens highlights the adaption of #SARSCoV2 to #NKcells of the innate immune system. #Immunology
Very excited to see our most recent data online at PLOS Pathogens! It is the third chapter of our work on host-pathogen interactions between NK cells and SARS-CoV-2, focussing on HLA-E-restricted peptides. This time, we follow virus 🦠 evolution: tinyurl.com/yc562a4e
Thrilled to announce that @Vetenskapsradet has awarded us a starting grant to support our research on #virus & #immune cell interactions at @CIM_Sweden @karolinskainst Grateful for this support and very excited to see where this journey leads! tinyurl.com/ydb7cp95
Thanks for highlighting our latest preprint, Steve! Although a really minor contribution to the field, it may provide some technical insights and could potentially be relevant for guiding future studies on the topic
Human NK cell responses to the SARS-CoV-2 Spike269-277 peptide YLQPRTFLL @QuirinHammer doi.org/10.1101/2024.0…
Preprint alert 🚨 Up to 90% CAR knock-in rates in primary human T cells - without drug enhancers? 🧐 Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells biorxiv.org/content/10.110… 🧵👇
IL-21 engineering enhances NK cell activity against glioblastoma via CEBPD @Cancer_Cell cell.com/cancer-cell/fu… @Dr_Nick_Bikes cell.com/cancer-cell/fu… @lab_rezvani @Mayrashanley
Thanks for highlighting our work 🙏🏻
Hammer et al. showed that deletion of genes for the CD54 (ICAM-1, binds LFA-1) and CD58 (LFA-3, binds CD2) adhesion molecules in B2M-/- (HLA-Ilo) target cells reduced their sensitivity to NK cell[...] bit.ly/3xQCjEx @QuirinHammer @MalmbergLab @karolinskainst
Love Immunology? Hate Cancer? Come join the Centre for Immuno-Oncology as a senior postdoc in Immunopeptidomics. jobs.ac.uk/job/DIT166/sen…